Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Infants With Very High Risk KMT2A B-ALL: early-phase trial registry
1 of 1 indexed Infants With Very High Risk KMT2A B-ALL trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #11,370 of 28,707 conditions by registered trial count.
1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count
Infants With Very High Risk KMT2A B-ALL: 1 US clinical trial tracked, 1 recruiting.
Infants With Very High Risk KMT2A B-ALL is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Stephan Grupp MD PhD, running 1 of these trials.
Enrollment posture brief
Registry condition infants-with-very-high-risk-kmt2a-b-all
OPEN 1 | RECR 100% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
Infants With Very High Risk KMT2A B-ALL lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Infants With Very High Risk KMT2A B-ALL on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Infants With Very High Risk KMT2A B-ALL is recruiting above its size-band peers.
1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
1 total, page 1 of 1
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Infants With Very High Risk KMT2A B-ALL records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Infants With Very High Risk KMT2A B-ALL trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Infants With Very High Risk KMT2A B-ALL page
1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Infants With Very High Risk KMT2A B-ALL trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Stephan Grupp MD PhD sponsors the most Infants With Very High Risk KMT2A B-ALL trials on record, review their full trial history before evaluating a specific study. See Stephan Grupp MD PhD's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Infants With Very High Risk KMT2A B-ALL condition card totals 1 registered trials; most-linked intervention Murine CART19; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.